for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Baxter International Inc

BAX.N

Latest Trade

89.73USD

Change

-0.26(-0.29%)

Volume

1,978,970

Today's Range

89.22

 - 

89.89

52 Week Range

68.21

 - 

90.26

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Baxter Announces Preliminary Net Sales For The Fourth-Quarter And Full-Year 2019 And Announces Preliminary Full-Year 2020 Guidance

Jan 12 (Reuters) - Baxter International Inc <BAX.N>::BAXTER ANNOUNCES PRELIMINARY NET SALES FOR THE FOURTH-QUARTER AND FULL-YEAR 2019 AND ANNOUNCES PRELIMINARY FULL-YEAR 2020 GUIDANCE.Q4 SALES $3.0 BILLION VERSUS REFINITIV IBES ESTIMATE OF $2.94 BILLION.EXPECTS NET SALES GROWTH OF 4% TO 5% ON BOTH A REPORTED AND CONSTANT CURRENCY BASIS FOR FULL YEAR 2020.

Baxter International Says Co Entered Into A $2 Billion, Five-Year Revolving Credit Agreement

Dec 20 (Reuters) - Baxter International Inc <BAX.N>::BAXTER INTERNATIONAL - ENTERED INTO A $2.0 BILLION, FIVE-YEAR REVOLVING CREDIT AGREEMENT.BAXTER INTERNATIONAL - MAY SEEK TO INCREASE AGGREGATE COMMITMENT UNDER CREDIT AGREEMENT BY UP TO $1.0 BILLION WITH MAXIMUM COMMITMENT OF UP TO $3.0 BILLION.BAXTER INTERNATIONAL - CREDIT AGREEMENT REPLACES BAXTER’S $1.5 BILLION FIVE-YEAR REVOLVING CREDIT AGREEMENT DATED AS OF JULY 1, 2015.BAXTER INTERNATIONAL - BAXTER HEALTHCARE SA & BAXTER WORLD TRADE SPRL ENTERED INTO A €200 MILLION, FIVE-YEAR REVOLVING CREDIT AGREEMENT.BAXTER INTERNATIONAL- MAY SEEK TO INCREASE AGGREGATE COMMITMENT UNDER EURO CREDIT AGREEMENT BY UP TO €100 MILLION WITH MAXIMUM COMMITMENT OF UP TO €300 MILLION.

Baxter To Expand Advanced Surgery Portfolio With Acquisition Of Seprafilm Adhesion Barrier

Dec 2 (Reuters) - Baxter International Inc <BAX.N>::BAXTER TO EXPAND ADVANCED SURGERY PORTFOLIO WITH ACQUISITION OF SEPRAFILM ADHESION BARRIER.BAXTER INTERNATIONAL INC - TRANSACTION CONTEMPLATES A CASH PURCHASE PRICE AT CLOSING OF $350 MILLION.BAXTER INTERNATIONAL INC - SALES OF PROPOSED ACQUIRED PRODUCTS ARE EXPECTED TO BE APPROXIMATELY $100 MILLION IN 12 MONTHS FOLLOWING CLOSE..

Baxter International Declared Quarterly Cash Dividend Of $0.22/Shr

Nov 19 (Reuters) - Baxter International Inc <BAX.N>::BAXTER INTERNATIONAL INC - DECLARED A QUARTERLY CASH DIVIDEND OF $0.22 PER SHARE OF COMMON STOCK.

Third Point Dissolves Stake In Netflix, Cuts In Baxter, Tradeweb and Adobe

Nov 14 (Reuters) - Third Point Llc::THIRD POINT LLC DISSOLVES SHARE STAKE IN NETFLIX INC - SEC FILING.THIRD POINT LLC DISSOLVES SHARE STAKE IN TWILIO INC.THIRD POINT LLC DISSOLVES SHARE STAKE IN ZOOM VIDEO COMMUNICATIONS INC.THIRD POINT LLC CUTS SHARE STAKE IN BAXTER INTERNATIONAL INC BY 26.7 PERCENT TO 16.9 MILLION SHARES.THIRD POINT LLC CUTS SHARE STAKE IN TRADEWEB MARKETS INC BY 57.5 PERCENT TO 425,000 CLASS A SHARES.THIRD POINT LLC UPS SHARE STAKE IN SALESFORCE.COM INC BY 92.3 PERCENT TO 2.5 MILLION SHARES.THIRD POINT LLC CUTS SHARE STAKE IN ADOBE INC BY 10.8 PERCENT TO 825,000 SHARES.THIRD POINT LLC DISSOLVES SHARE STAKE IN ROSS STORES INC.THIRD POINT LLC - CHANGE IN HOLDINGS ARE AS OF SEPTEMBER 30, 2019 AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF JUNE 30, 2019.

Baxter International Appoints Karen Leets As Treasurer

Oct 28 (Reuters) - Baxter International Inc <BAX.N>::BAXTER INTERNATIONAL INC - APPOINTS KAREN LEETS AS TREASURER.BAXTER INTERNATIONAL INC - LEETS MOST RECENTLY SERVED AS ASSISTANT TREASURER, TREASURY OPERATIONS WITH ALPHABET INC.BAXTER INTERNATIONAL - EXPECTS LEETS WILL SERVE IN INTERIM ROLE WHILE SHE ASSISTS CO WITH ONGOING EVALUATION OF INTERNAL CONTROLS, AMONG OTHER THINGS.

Baxter Launches Prismax In Canada To Maximize Treatment In ICU

Aug 12 (Reuters) - Baxter International Inc <BAX.N>::BAXTER LAUNCHES PRISMAX IN CANADA TO MAXIMIZE TREATMENT IN THE INTENSIVE CARE UNIT.BAXTER CANADA - ANNOUNCED HEALTH CANADA'S APPROVAL OF ITS PRISMAX SYSTEM AND INTEGRATED THERMAX BLOOD WARMER.BAXTER CANADA - EXPECTS TO FILE FOR REGULATORY APPROVAL OF PRISMAX IN ADDITIONAL COUNTRIES IN 2019 AND 2020.

Baxter Reports Second Quarter GAAP Earnings Per Share Of $0.66

July 25 (Reuters) - Baxter International Inc <BAX.N>::BAXTER REPORTS SECOND-QUARTER 2019 RESULTS.Q2 GAAP EARNINGS PER SHARE $0.66.Q2 EARNINGS PER SHARE ESTIMATE $0.81 -- REFINITIV IBES DATA.SEES Q3 2019 ADJUSTED EARNINGS PER SHARE $0.82 TO $0.84 FROM CONTINUING OPERATIONS EXCLUDING ITEMS.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $3.34 TO $3.40 FROM CONTINUING OPERATIONS EXCLUDING ITEMS.SEES Q3 2019 GAAP EARNINGS PER SHARE $0.75 TO $0.78 FROM CONTINUING OPERATIONS.SEES FY 2019 GAAP EARNINGS PER SHARE $2.81 TO $2.89 FROM CONTINUING OPERATIONS.Q2 REVENUE $2.8 BILLION VERSUS REFINITIV IBES ESTIMATE OF $2.79 BILLION.BAXTER INTERNATIONAL - PLANS TO SCALE INVESTMENTS IN U.S. TO ALIGN WITH PROPOSED MODELS FROM CMS AND PATIENT AND MARKET DYNAMICS ACROSS ADOPTION CURVE.BAXTER INTERNATIONAL - INVESTMENTS ARE ANTICIPATED AT $500 MILLION IN POTENTIAL NEW U.S. FACILITIES & IN EXISTING SITES.BAXTER INTERNATIONAL - ANTICIPATES THE INVESTMENTS TO HELP ACCELERATE RENAL CARE GROWTH,CONTRIBUTE POSITIVELY TO CO'S PREVIOUS FINANCIAL COMMITMENTS.EXPECTS Q3 SALES GROWTH OF 3% TO 4% ON A REPORTED BASIS.BAXTER INTERNATIONAL - SEES FY SALES GROWTH OF 1% TO 2% ON A REPORTED BASIS, AND APPROXIMATELY 4% ON BOTH A CONSTANT CURRENCY AND OPERATIONAL BASIS.EXPECTS Q3 SALES TO GROW APPROXIMATELY 5% ON BOTH A CONSTANT CURRENCY AND OPERATIONAL BASIS.Q3 EARNINGS PER SHARE VIEW $0.86, REVENUE VIEW $2.84 BILLION -- REFINITIV IBES DATA.FY2019 EARNINGS PER SHARE VIEW $3.33, REVENUE VIEW $11.21 BILLION -- REFINITIV IBES DATA.

Baxter Announces U.S. FDA Approval Of Myxredlin, Ready-To-Use Insulin For IV Infusion

July 22 (Reuters) - Baxter International Inc <BAX.N>::BAXTER ANNOUNCES U.S. FDA APPROVAL OF MYXREDLIN, THE FIRST AND ONLY READY-TO-USE INSULIN FOR IV INFUSION.BAXTER INTERNATIONAL INC - MYXREDLIN IS EXPECTED TO BE AVAILABLE FROM BAXTER IN UNITED STATES BEFORE END OF YEAR.BAXTER INTERNATIONAL INC- OFFERS EXTENDED SHELF LIFE OF 30 DAYS AT ROOM TEMPERATURE OR 24 MONTHS REFRIGERATED.BAXTER INTERNATIONAL - MYXREDLIN OFFERS EXTENDED SHELF LIFE OF 30 DAYS AT ROOM TEMPERATURE OR 24 MONTHS REFRIGERATED (ADDS DROPPED WORD).

Baxter International Declares Qtrly Cash Dividend Of $0.22 Per Share

July 16 (Reuters) - Baxter International Inc <BAX.N>::SETS QUARTERLY CASH DIVIDEND OF $0.22PER SHARE.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up